First developed in the 1960s, tranexamic acid, an inhibitor of plasminogen activation and fibrinolysis, found niche applications in treating hereditary bleeding disorders. The indications for drugs ...

July 30, 2024 — A new study finds that giving a fatty acid inhibitor alongside chemotherapy could improve the treatment efficacy for patients with brain metastases from triple negative breast ...

A retrospective study revealed that the link between early-life acid-suppressive therapy use and celiac disease autoimmunity may be confounded by healthcare utilization behavior.

Pantoprazole can interact with many medications, including drugs that treat cancer, iron supplements, and HIV medicines, ...

Proton pump inhibitors (PPIs) are a class of very effective ... Rolaids, and Tums, or acid-reducing drugs known as H2 blockers, such as cimetidine (Tagamet), famotidine (Pepcid), nizatidine ...

Huons Global Co. Ltd. has described reversible H+/K+ ATPase inhibitors, particularly acid pump antagonists (APA), reported to be useful for the treatment of gastric and duodenal ulcers, gastritis, ...

Qfitlia (fitusiran) is the first therapy for both hemophilia A or B, with or without inhibitors, available in the United ...